TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
CTMX

CytomX Therapeutics Inc

Healthcare · Biotechnology

2.60$ -0.4% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

CytomX Therapeutics Inc (CTMX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 381 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CTMX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
193 199 178 352 387 398 376 377 483 457 445 405 373 341 437 402 375 359 434 402 371 339 297 260 226 261 235 209 221 202 185 159 139 121 98 175 158 152 359 381
183 188 167 341 376 389 367 367 473 445 405 367 335 303 400 367 340 324 400 271 241 310 268 233 200 237 212 188 201 183 167 143 124 107 87 165 149 144 353 373
60 105 86 273 284 178 142 133 260 248 190 149 165 188 143 291 177 192 330 256 236 206 163 129 95 194 56 58 26 17 36 43 41 38 48 49 34 13 29 17
178 182 163 336 331 374 361 335 465 436 397 349 326 296 248 346 321 316 394 266 236 305 263 228 194 194 205 181 194 175 150 137 118 101 80 158 144 137 347 330
0.4 2.3 0.3 0.2 40 10 0.1 25 0.1 0.1 0.0 10 0.0 0.0 143 13 14 0.8 0.8 0.9 0.9 0.8 1.0 1.0 1.7 36 1.1 1.9 2.4 3.4 13 2.8 3.4 3.1 2.0 1.9 1.6 2.0 0.6 37
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 0.0 – – 0.0 0.0 – – 0.0 0.0 0.0 0.0 0.0 0.0 – 0.0 – 0.0 0.0 0.0 – – – – – – – – – – –
3.7 4.4 4.6 4.3 4.1 4.2 4.6 5.5 5.5 6.9 35 34 33 33 32 31 7.2 7.0 7.2 28 6.3 6.0 6.1 24 23 6.0 4.6 4.5 – – – – – – – – – – – –
0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9
1.8 1.8 1.8 1.8 1.6 1.6 1.6 1.5 1.5 1.5 1.4 1.4 1.3 1.3 1.3 1.2 1.2 1.2 1.1 1.1 1.1 1.0 1.0 0.9 0.9 0.9 0.8 0.8 0.8 0.7 0.7 0.7 0.6 0.6 0.5 0.5 0.5 0.4 0.4 0.4
103 121 104 300 342 328 327 336 325 326 322 304 290 290 367 344 327 366 288 271 260 340 229 211 198 347 321 294 272 249 216 190 162 121 73 55 51 53 39 79
24 36 37 61 71 61 70 83 86 98 96 79 76 86 106 99 102 68 98 93 100 78 103 99 98 153 151 141 147 156 145 143 119 86 50 39 41 47 34 40
– – – – – – 1.0 2.7 5.0 13 2.5 2.6 2.7 2.8 2.9 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 4.0 4.1 4.2 4.3 4.5 4.6 4.7 4.9 5.0 5.1 5.3 5.4 5.6 4.2 2.9 1.5
0.5 6.6 3.7 6.4 2.9 4.2 5.3 4.2 6.9 5.1 9.5 4.5 4.6 4.2 3.8 4.9 3.6 3.0 2.6 1.8 1.5 2.8 1.7 1.9 5.2 2.8 2.2 1.0 1.7 1.5 2.0 0.6 1.4 1.1 0.3 0.2 0.6 1.3 1.4 1.9
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 27 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
89 78 74 52 45 70 50 41 158 131 123 102 82 51 70 59 48 -7.8 146 131 112 -0.5 68 49 28 -86 -87 -85 -51 -47 -32 -31 -23 -0.5 25 120 107 99 320 302
-162 -176 -185 -210 -220 -219 -246 -259 -283 -315 -329 -358 -382 -417 -405 -421 -435 -508 -466 -485 -507 -624 -558 -582 -605 -723 -726 -727 -724 -723 -710 -716 -710 -692 -668 -668 -682 -712 -730 -751
36 37 37 37 37 39 39 39 44 45 45 45 45 46 47 46 46 46 61 65 65 65 65 66 66 66 66 67 81 67 83 85 85 80 87 129 165 170 177 219

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?